Upon completion of this program, participants should be better able to:
-Discuss the rationale for combination therapy in cancer care
-Compare and contrast adverse effects related to the use of targeted therapies, immunotherapy, and cytotoxic chemotherapy
-Describe the impact on adverse effects when targeted therapies are combined with checkpoint inhibitors or cytotoxic chemotherapy
-Formulate effective strategies to monitor for and manage adverse events in patients receiving targeted therapies in combination with chemotherapy or immunotherapy
